Showing 1,261 - 1,280 results of 1,901 for search 'replacement control methods', query time: 0.14s Refine Results
  1. 1261
  2. 1262
  3. 1263

    Evaluation of Retention and Fracture Strength of All Ceramic Crowns with Three Different Esthetic Cast Post–Core Systems by Sina Safari, Amirmohammad Mirzapour, Roya Sadrmohammadi

    Published 2023-01-01
    “…There were no discernible distinctions among the three study methods regarding fracture strength. Nonetheless, the retention strength of the IPS group resembled that of the control group, surpassing that of the composite and ceramic groups.…”
    Get full text
    Article
  4. 1264

    TRANSCATHETER AORTIC VALVE IMPLANTATION IN PATIENTS WITH LEFT ATRIAL APPENDIX THROMBUS by Hüseyin Ayhan, Tahir Durmaz, Telat Keleş, Abdullah Nabi Aslan, Cenk Sarı, Hacı Ahmet Kasapkara, Emine Bilen, Nihal Akar Bayram, Murat Akçay, Engin Bozkurt

    Published 2014-01-01
    “…With this study we aimed to evaluate the TAVI efficacy and reliability on patients with scarcely relative contraindication and with intracardiac thrombus who are mostly left out of the study.Methods and Results. There has been a successful TAVI process conducted in our clinic for antiplatelet and anticoagulation for 6 cases in which thrombus was seen in left atrial appendix (LAA) via transesophageal echocardiography (TEE) and which are not suitable for surgical valve replacement due to atrial fibrillation (AF) and severe AS comorbid reasons. …”
    Get full text
    Article
  5. 1265

    The Effect of Advanced Platelet-Rich Fibrin Plus (A-PRF+) on Graft Stability in Dental Implants and Alveolar Ridge Augmentation Procedures: A New Low-Speed Standardized Centrifugat... by Benjamin Walch, Andreas Kolk, Dominik Scheibl, Maria Guarda, Sarah Christine Maier, Lena Denk

    Published 2024-10-01
    “…PRF can be mixed with bone replacement material to form sticky bone, which is then introduced into the desired area for stabilizing and graft-covering. …”
    Get full text
    Article
  6. 1266

    Understanding Public Judgements on Artificial Intelligence in Healthcare: Dialogue Group Findings From Australia by Emma K. Frost, Yves Saint James Aquino, Annette Braunack‐Mayer, Stacy M. Carter

    Published 2025-04-01
    “…They were opposed to HCAI as a decision‐making tool or as a replacement for physician–patient interaction. Conclusion Our findings indicate that Australians support HCAI as a tool that enhances rather than replaces human decision‐making in health care. …”
    Get full text
    Article
  7. 1267

    Effect of microstructure differences on the thermal and mechanical behaviors of porous cementitious composites using phase change materials by Md Suman Mia, Satya Medepalli, Yuya Takahashi, Koichi Tsuchiya, Tetsuya Ishida

    Published 2025-01-01
    “…The thermal behavior was measured in a temperature-controlled environmental chamber by placing a thermocouple at the center of the 100 mm cube specimens. …”
    Get full text
    Article
  8. 1268
  9. 1269

    Impact of codon optimization on vip3Aa11 gene expression and insecticidal efficacy in maize by Shengyan Li, Ning Wen, Wenjie Lv, Wenjie Lv, Mingjun Zhang, Yinxiao Wang, Zhihong Lang, Zhihong Lang

    Published 2025-05-01
    “…The vip3Aa11 gene from Bacillus thuringiensis is a promising candidate for controlling Spodoptera frugiperda.Methods and resultsTo develop insect-resistant maize, we designed two codon-optimized vip3Aa11 variants (vip3Aa11-m1 and vip3Aa11-m2) based on maize codon usage bias. …”
    Get full text
    Article
  10. 1270

    Risk Factors for MAFLD and Advanced Liver Fibrosis in Adult-Onset Craniopharyngioma Patients: A Cross-Sectional Study by Chen L, Wu W, Ye H

    Published 2025-03-01
    “…Strategies such as controlling weight gain, maintaining optimal blood glucose and blood pressure levels, appropriate hormone replacement, and avoiding excessive glucocorticoid use should be implemented to prevent and delay the onset and progression of MAFLD and ALF.Keywords: craniopharyngioma, adult-onset, hypopituitarism, metabolic dysfunction-associated fatty liver disease, advanced liver fibrosis…”
    Get full text
    Article
  11. 1271

    Utilizing PROSE as a Drug Delivery Device for Preservative-Free Cyclosporine 0.05% for the Treatment of Dry Eye Disease: A Pilot Study by Nakhla MN, Patel R, Crowley E, Li Y, Peiris TB, Brocks D

    Published 2024-11-01
    “…Monica Nabil Nakhla,1 Ria Patel,1 Estelle Crowley,2 Yichen Li,3 Thelge Buddika Peiris,3 Daniel Brocks2 1Tufts University School of Medicine, Boston, MA, USA; 2Department of Ophthalmology, BostonSight, Needham, MA, USA; 3Department of Mathematical Sciences, Worcester Polytechnic Institute, Worcester, MA, USACorrespondence: Daniel Brocks, Department of Ophthalmology, BostonSight, Needham, MA, USA, Tel +1 781 726 7337, Fax +1 781 726 7310, Email dbrocks@bostonsight.orgPurpose: To evaluate the tolerability of utilizing Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) as a drug delivery device for preservative-free cyclosporine 0.05% for the treatment of dry eye disease.Patients and Methods: Fourteen current daily PROSE wearers were enrolled, with four screen failures and one subject that did not complete the study protocol due to burning and stinging. …”
    Get full text
    Article
  12. 1272
  13. 1273

    Successful eradication of acquired factor VIII inhibitors with rituximab: a report of two cases by Ma'in Abumuhfouz, Anas Al-sadi, Awni Alshurafa, Israa Jawarneh, Ruba Y. Taha, Sarah A. Elkourashy

    Published 2024-12-01
    “…Given its potential benefits, further randomized controlled trials are warranted to evaluate rituximab's role as a first-line treatment. …”
    Get full text
    Article
  14. 1274

    Retinoblastoma Morphology after Local Chemotherapy by S. V. Saakyan, I. P. Khoroshilova-Maslova, S. S. Tadevosyan, A. Yu. Tsygankov, G. P. Zakharova, O. A. Ivanova, O. G. Panteleeva, A. A. Zharua

    Published 2021-10-01
    “…Significant changes in the tumor tissue such as tumor regression associated with the destruction of the tumor tissue and its replacement with fibrous tissue, glia proliferation, and the formation of petrificates were revealed. …”
    Get full text
    Article
  15. 1275

    Is It Time to Revisit the Role of Interleukin-1 Inhibitors in Osteoarthritis? by Brom M, Saxer F, Mindeholm L, Schieker M, Conaghan PG

    Published 2025-05-01
    “…Interleukin-1 (IL-1) plays a key role in the development of OA, but the results of clinical trials targeting IL-1 in OA have to date been disappointing.Methods: This narrative review is based on a literature search for publications describing interventions with direct Il-1 pathway inhibitors in patients with knee OA and substantiated by a description of key pre-clinical observations.Results: Randomized controlled studies using IL-1 inhibition as treatment approach to knee OA have read out negatively, although trends for an improvement in pain and impact on biomarkers could be observed. …”
    Get full text
    Article
  16. 1276

    Lipid abnormality correction by integrase inhibitor among children taking ARt by A. V. Samarina, N. S. Dyldina, E. K. Fertikh, E. B. Yastrebova, I. A. Abramova, D. A. Gusev

    Published 2019-10-01
    “…Time horizon of observation and laboratory control after boosted PI switch was 24 months. Results. …”
    Get full text
    Article
  17. 1277

    IN VITRO TESTING OF CLOVE EXTRACTS IN INHIBITING AND KILLING STAPHYLOCOCCUS AUREUS AND ESCHERICHIA COLI by Nadia Dwi Rahmawati, Tri Nur Kristina, Endang Sri Lestari, Hardian Hardian

    Published 2021-01-01
    “…MIC was measured with dilution method, while MBC with streak method. Negative controls were only used to monitor the quality of this work. …”
    Get full text
    Article
  18. 1278
  19. 1279

    Study on the evolution mechanism of mechanical properties of recycled concrete excited by different alkali content at high temperature by Qing Su, Zhixiong Tao

    Published 2025-04-01
    “…IntroductionAt present, the gradual reduction of sand and gravel stock is very unfavorable to the preparation of recycled concrete.MethodsTherefore, this study focused on alkali excited recycled concrete with different dosage of copper slag, and set different high temperature methods to test its mechanical properties.ResultsThe results showed that: 1) The residual compressive strength of the control group was not as good as that of the experimental group under other high temperature effects except for the experimental group under 400°C; 2) After high temperature action at 200°C, the ratios of A30, B30 and C30 relative to normal temperature are 1.07, 1.11 and 1.12 respectively, which are slightly higher than those after high temperature action at 400°C, indicating that the use of a certain amount of copper slag to replace fine aggregate quartz sand is helpful to improve the performance of alkali-stimulated recycled concrete at high temperature; 3) The flexural strength of A30 and A60 was 1.410 times and 1.371 times that of the control group after high temperature reaction at 800°C, indicating that the addition of copper slag had a positive impact on the flexural strength of alkali stimulated recycled concrete. 4) After treatment at 200°C, the bending strength ratios of control groups, A30, A60 and A100 were 0.676, 0.748, 0.728 and 0.687, respectively, while after treatment at 600°C, the corresponding ratios were 0.349, 0.440, 0.437 and 0.382, respectively, indicating that the addition of copper slag in high temperature environment, the bending strength ratio of control groups was 0.676, 0.748, 0.728 and 0.687, respectively.DiscussionIt can improve the flexural strength of alkali excited recycled concrete. …”
    Get full text
    Article
  20. 1280

    Humoral response to mRNA vaccines against SARS-CoV-2 in patients with humoral immunodeficiency disease. by Michaela Bitzenhofer, Franziska Suter-Riniker, Matthias B Moor, Daniel Sidler, Michael P Horn, Anna Gschwend, Cornelia Staehelin, Andri Rauch, Arthur Helbling, Lukas Jörg

    Published 2022-01-01
    “…The aim of this study was to evaluate the humoral immune response after two vaccine doses with BNT162b2 or mRNA-1273 in patients with humoral immunodeficiency disease.<h4>Methods</h4>This cross-sectional study assessed 39 individuals with hypogammaglobulinemia under immunoglobulin replacement therapy. …”
    Get full text
    Article